Xiao Xu

Adverse outcomes from initiation of systemic corticosteroids for asthma: long-term observational study

D. Price, M. Kerkhof, T. Tran, 2018, Journal of asthma and allergy.

The association between blood eosinophil count and benralizumab efficacy for patients with severe, uncontrolled asthma: subanalyses of the Phase III SIROCCO and CALIMA studies

I. Hirsch, J. Zangrilli, M. Goldman, 2017, Current medical research and opinion.

Symptomatic burden of COPD for patients receiving dual or triple therapy

M. Small, Xiao Xu, Stephanie Chen, 2017, International journal of chronic obstructive pulmonary disease.

Matching‐adjusted comparison of oral corticosteroid reduction in asthma: Systematic review of biologics

D. Husereau, N. Molinari, A. Bourdin, 2020, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

Matching-adjusted indirect comparison of benralizumab versus interleukin-5 inhibitors for the treatment of severe asthma: a systematic review

D. Husereau, N. Molinari, A. Bourdin, 2018, European Respiratory Journal.

Systematic literature review of the clinical, humanistic, and economic burden associated with asthma uncontrolled by GINA Steps 4 or 5 treatment

S. Golam, Xiao Xu, Stephanie Chen, 2018, Current medical research and opinion.

Benralizumab for chronic obstructive pulmonary disease and sputum eosinophilia: a randomised, double-blind, placebo-controlled, phase 2a study.

E. Bleecker, C. Brightling, R. Panettieri, 2014, The Lancet. Respiratory medicine.

Healthcare resource utilization and costs associated with incremental systemic corticosteroid exposure in asthma

D. Price, M. Kerkhof, T. Tran, 2018, Allergy.

Daily patient-reported health status assessment improvements with benralizumab for patients with severe, uncontrolled eosinophilic asthma

I. Hirsch, S. O'Quinn, Xiao Xu, 2019, Journal of asthma and allergy.

Conceptualization Of Symptoms And Symptom Impacts Among Adults With Inadequately Controlled Modererate-Severe Asthma

A. Hareendran, S. O'Quinn, K. McLaurin, 2012, ATS 2012.

Daily patient-reported health status assessment improvements with benralizumab for patients with severe, uncontrolled eosinophilic asthma

I. Hirsch, S. O'Quinn, Xiao Xu, 2019, Journal of asthma and allergy.